This patent covers the use of the retinoid receptor pathway to induce differentiation of adipocyte stem cells in vivo and therefore make a patient who is insulin resistant, insulinn sensitive.
View this patent on the USPTO website.
 
  
  
  
  
  
  
  
  
  
  
       
    Add Comment
 Add CommentYou must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.